Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study

NCT02615249 is registered in ClinicalTrials.gov with Allerderm as lead sponsor.

NCT NCT02615249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02615249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study
Lead sponsor
Allerderm
Phase
Phase 2
Overall status
Completed
Start date
December 5, 2016
Completion date
July 15, 2019
Enrollment
122 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, eczematous